Robeco Institutional Asset Management
ITOS

Robeco Institutional Asset Management’s iTeos Therapeutics ITOS Stock Holding History

Robeco Institutional Asset Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,014
Closed -$57K – 999
2022
Q3 		$57K Hold
3,014
– – ﹤0.01% 911
2022
Q2 		$62K Hold
3,014
– – ﹤0.01% 893
2022
Q1 		$97K Buy
+3,014
New +$110K ﹤0.01% 878

Other funds holding ITOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Robeco Institutional Asset Management's ITOS Position: Q4 2022 in Review

Robeco Institutional Asset Management sold out of iTeos Therapeutics (ITOS) in Q4 2022, closing a stake of 3,014 shares — an estimated $57K sold.

Robeco Institutional Asset Management first reported a position in ITOS in Q1 2022 and held it in 3 quarters. The position peaked at $97K in Q1 2022. 146 funds tracked by Wall St. Rank hold ITOS as of Q4 2022.

  • Robeco Institutional Asset Management reported no remaining iTeos Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 3,014 iTeos Therapeutics shares in Q4 2022, an estimated $57K.
  • Robeco Institutional Asset Management first reported a position in iTeos Therapeutics in Q1 2022 and held it in 3 quarters.
  • Robeco Institutional Asset Management's iTeos Therapeutics position peaked at $97K in Q1 2022.
  • 146 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2022.

Based on Robeco Institutional Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.